In support of the human relevance of our work, we show that many of the alterations in serum levels of tryptophan metabolites seen in the knockout mice are also observed in humans after administration of probenecid, a drug used to treat gout that inhibits OAT1 and OAT3. Here, SLC22A8 is linked to gout.